MedTrace Logo

A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine

NCT00516399 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2014-12-04

No results posted yet for this study

Summary

The purpose of this study is to determine the effectiveness of 1.25% povidone-iodine ophthalmic solution for the treatment of small to medium sized fungal corneal ulcers compared with an antifungal antibiotic.

Conditions

  • Fungal Keratitis

Interventions

DRUG

povidone-iodine 1.25% ophthalmic solution

DRUG

natamycin ophthalmic suspension, USP 5%

Sponsors & Collaborators

Principal Investigators

  • Sherwin J. Isenberg, M.D. · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-09-30
Completion
2010-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00516399 on ClinicalTrials.gov